The mutually-established, prescribed plan for management of chronic pain, often includes opioids. While convenient and often effective, concerns include significant side effects, addiction, dependency, and withdrawal for patients and opioid crisis pressures from regulatory agencies and insurer pressure for clinicians. How can patients, their caretakers and clinicians work together to ensure adequate and safe pain relief?
In this webinar, we will hear from an engaged patient advocate as he shares his experiences navigating through the health care system, his advice and recommendations on how to build a trusting relationship with your provider, and how technology can assist in encouraging conversation and discussion regarding pain management. These challenges and solutions vary widely. As this is one person's perspective and not a definitive roadmap, we welcome you, our attendee, to submit questions and experiences regarding this topic for our presenter to address.
He is an action catalyst empowering people traveling together toward best health, writing, speaking, and advising on learning what works for people in their health journey: informed decision-making, patient-centered research, communication at transitions of care, and technology supporting solutions created by and for people.
Danny consults about patient engagement and informed decision making about pain management choices. Serves on the Steering Committee of AHRQ’s Patient-Centered Clinical Decision Support (PCCDS) Learning Network. Reviews PCORI research funding applications and serves as co-chair of PCORI’s Clinical Effectiveness and Decision Science (CEDS) Advisory Panel. Technical expert for the CMS-funded Supporting Efficiency and Innovation in the Process of Developing CMS Quality Measures. Participating in the National Academy of Medicine’s Digital Learning Collaboratives on Patient Ownership of Health Data and Health Data Sharing, Linkage, and Use. Spoke about patient-centered decisions and patient engagement at the Medical Group Management Association and for the International Waldenstrom’s Macroglobulinemia Foundation.